Skip to Main Content

Author Details

David Croteau
Division of Pharmacovigilance I, Center for Drug Evaluation and Research
2001
38
22
PMIDPaper TitleJournal TitlePublished Year
37706451Immune-mediated colitis associated with ocrelizumab: A new safety risk.Mult Scler2023
35113347Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration.Drug Saf2022
35489029Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.J Clin Psychopharmacol2022
32662718Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation.Mult Scler2021
33423274Hypertension: A new safety risk for patients treated with erenumab.Headache2021
33300850Expanding spectrum of opportunistic infections associated with dimethyl fumarate.Mult Scler2021
32323442Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.Pharmacoepidemiol Drug Saf2020
29685284HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau.J Neuroimmunol2018
29602912Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab.Neurology2018
27379819Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.J Addict Med2016
26407716Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.J Neurovirol2016
23143899Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.J Antimicrob Chemother2013
23838849Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.J Neurovirol2013
23335197Etravirine in CSF is highly protein bound.J Antimicrob Chemother2013
22290964Therapeutic amprenavir concentrations in cerebrospinal fluid.Antimicrob Agents Chemother2012
22313954Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration.AIDS2012
20563833Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.J Neurooncol2011
20020841Poor drug distribution as a possible explanation for the results of the PRECISE trial.J Neurosurg2010
20876368Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.Antimicrob Agents Chemother2010
20511192Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.Neuro Oncol2010
20431907Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis.J Neurooncol2010
19011763Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma.J Neurooncol2009
17435179Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.Neuro Oncol2007
18091279Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.Neurosurgery2007
17639894Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note.J Neurosurg2007
17312057Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.AJR Am J Roentgenol2007
17297371Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.Neurosurgery2007
17327604Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.J Clin Oncol2007
16700620Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.Technol Cancer Res Treat2006
16709020Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.Neurosurg Focus2006
15739554Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.J Neurosurg2005
15658101Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer.J Neurosurg2005
12234397Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.Neurosurgery2002
11524490Response to cancer therapy in a patient with a paraneoplastic choreiform disorder.Neurology2001
11394434Acalculous cholecystitis in a two year old.JSLS2001
11692657New innovations and developments for glioma treatment.Clin Neurosurg2001
11564242Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.Neurosurgery2001
12057096Adults with newly diagnosed high-grade gliomas.Curr Treat Options Oncol2001
  • 1 - 38 of 38

Recommended Authors

Jonathan W Rick
University of Arkansas for Medical Sciences
Career Start Year 2015
Number of shared co-authors 2
Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 0
Muhammad Husnain
University of Arizona
Career Start Year 2011
Number of shared co-authors 0
Maryam Rahman
University of Florida
Career Start Year 2008
Number of shared co-authors 0
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 2
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 4
Benjamin M Greenberg
The University of Texas Southwestern Medical Center
Career Start Year 2003
Number of shared co-authors 1
Mariza Daras
University of California san francisco
Career Start Year 2001
Number of shared co-authors 6
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Stefan Oberndorfer
Karl Landsteiner University of Health Sciences
Career Start Year 1999
Number of shared co-authors 0
Jaishri O Blakeley
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 5
Henrikas Vaitkevicius
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 0
Bradley M Keegan
College of Medicine, Mayo Clinic
Career Start Year 1998
Number of shared co-authors 0
Tracy T Batchelor
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 7
Nam D Tran
Moffitt Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Ling-Yuan Kong
The University of Texas MD Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 3
Robert J Weil
Rhode Island Hospital
Career Start Year 1992
Number of shared co-authors 7
Jian-Qiang Lu
McMaster University
Career Start Year 1991
Number of shared co-authors 0
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 0
Bob S Carter
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1990
Number of shared co-authors 7
Morris D Groves
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 5
Bruce H Cohen
Akron Children's Hospital
Career Start Year 1988
Number of shared co-authors 2
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 6
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 0
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year 1986
Number of shared co-authors 9
Maria Sonia S Salamat
University of Wisconsin School of Medicine and Public Health
Career Start Year 1980
Number of shared co-authors 2
Leslie M Shaw
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 4
David Schiff
University of Virginia School of Medicine
Career Start Year 1966
Number of shared co-authors 8
Maria Martinez-Lage
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 2
Guy M McKhann
New York Presbyterian Hospital, Columbia University Medical Center
Career Start Year 1959
Number of shared co-authors 2

Collaborators

Raj K Puri
Co-authored papers 10
Scott L Letendre
University of California, university of california san diego
Co-authored papers 8
David B Clifford
Washington University School of Medicine
Co-authored papers 7
Susan Morgello
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Igor Grant
University of California San Diego
Co-authored papers 7
Ann C Collier
University of Washington
Co-authored papers 7
Ronald J Ellis
University of California
Co-authored papers 7
Benjamin B Gelman
University of Texas Medical Branch
Co-authored papers 7
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers 6
Christina M Marra
University of Washington
Co-authored papers 6
John Allen McCutchan
University of California San Diego
Co-authored papers 6
David M Simpson
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Justin C McArthur
Johns Hopkins School of Medicine
Co-authored papers 6
Michael D Prados
University of California san francisco
Co-authored papers 4
Michael A Vogelbaum
Moffit Cancer Center
Co-authored papers 4
Mitchel S Berger
University of California san francisco
Co-authored papers 3
Jorge A Gutierrez
Case Western Reverse University School of Medicine
Co-authored papers 3
Edward H Oldfield
National Institutes of Health
Co-authored papers 2
Henry S Friedman
Co-authored papers 2
Lisa Scarpace
Co-authored papers 2
Mark Rosenblum
Henry Ford Hospital
Co-authored papers 2
Robert K Heaton
University of California
Co-authored papers 2
Darell D Bigner
Co-authored papers 2
Florin Vaida
School of Public Health, university of california san diego
Co-authored papers 2
Ralph E Coleman
Duke University School of Medicine
Co-authored papers 2
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
James M Provenzale
Duke University Medical Center
Co-authored papers 2
Walter Ling
University of California Los Angeles
Co-authored papers 1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Gerald J Dal Pan
Center for Drug Evaluation and Research
Co-authored papers 1
Release 1.2